My A. Tran, Ph.D. - Publications

2009 University of California, Irvine, Irvine, CA 

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Watters RJ, Kester M, Tran MA, Loughran TP, Liu X. Development and use of ceramide nanoliposomes in cancer. Methods in Enzymology. 508: 89-108. PMID 22449922 DOI: 10.1016/B978-0-12-391860-4.00005-7  0.36
2011 Jiang Y, DiVittore NA, Kaiser JM, Shanmugavelandy SS, Fritz JL, Heakal Y, Tagaram HR, Cheng H, Cabot MC, Staveley-O'Carroll KF, Tran MA, Fox TE, Barth BM, Kester M. Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer. Cancer Biology & Therapy. 12: 574-85. PMID 21795855 DOI: 10.4161/cbt.12.7.15971  0.36
2011 Soehnlen MK, Tran MA, Lysczek HR, Wolfgang DR, Jayarao BM. Identification of novel small molecule antimicrobials targeting Mycoplasma bovis. The Journal of Antimicrobial Chemotherapy. 66: 574-7. PMID 21393230 DOI: 10.1093/jac/dkq503  0.36
2010 Li SY, Tran MA. Infimum of the spectrum of Laplace-Beltrami operator on a bounded pseudoconvex domain with a Kähler metric of Bergman type Communications in Analysis and Geometry. 18: 375-395.  0.96
2009 Tran MA, Watts RJ, Robertson GP. Use of liposomes as drug delivery vehicles for treatment of melanoma. Pigment Cell & Melanoma Research. 22: 388-99. PMID 19493316 DOI: 10.1111/j.1755-148X.2009.00581.x  0.36
2008 Tran MA, Gowda R, Sharma A, Park EJ, Adair J, Kester M, Smith NB, Robertson GP. Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development. Cancer Research. 68: 7638-49. PMID 18794153 DOI: 10.1158/0008-5472.CAN-07-6614  0.36
2008 Tran MA, Smith CD, Kester M, Robertson GP. Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 3571-81. PMID 18519791 DOI: 10.1158/1078-0432.CCR-07-4881  0.36
2006 Sharma A, Tran MA, Liang S, Sharma AK, Amin S, Smith CD, Dong C, Robertson GP. Targeting mitogen-activated protein kinase/extracellular signal-regulated kinase kinase in the mutant (V600E) B-Raf signaling cascade effectively inhibits melanoma lung metastases. Cancer Research. 66: 8200-9. PMID 16912199 DOI: 10.1158/0008-5472.CAN-06-0809  0.36
Show low-probability matches.